Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page
- Check5 days agoChange DetectedNo additions or deletions are present in the provided changes, so the study page text remains unchanged according to the input.SummaryDifference0.1%

- Check12 days agoChange DetectedA funding attribution line '2017 ( U.S. NIH Grant/Contract )' was added to the study's official title area. The site revision was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check19 days agoChange DetectedNo additions or deletions were reported for this page. Therefore, the page content remains as currently shown in the Study Details section.SummaryDifference0.0%

- Check27 days agoChange DetectedNo text changes were detected in the supplied data. The study page content remains unchanged.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page's revision indicator was updated to v3.6.5, replacing the previous v3.6.4.SummaryDifference0.1%

- Check41 days agoChange DetectedThere are no text changes detected in the provided data for this study page. The content remains as published, with no updates to study details, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.